Exacerbations of COPD von Viniol, Christian, Vogelmeier, Claus F

Volltext

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulm... von Halpin, David M G, Criner, Gerard J, Papi, Alberto, Singh, Dave, Anzueto, Antonio, Martinez, Fernando J, Agusti, Alvar A, Vogelmeier, Claus F

Volltext

Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD von Wedzicha, Jadwiga A, Banerji, Donald, Chapman, Kenneth R, Vestbo, Jørgen, Roche, Nicolas, Ayers, R. Timothy, Thach, Chau, Fogel, Robert, Patalano, Francesco, Vogelmeier, Claus F

Volltext

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary von Agustí, Alvar, Celli, Bartolome R, Criner, Gerard J, Halpin, David, Anzueto, Antonio, Barnes, Peter, Bourbeau, Jean, Han, MeiLan K, Martinez, Fernando J, Montes de Oca, Maria, Mortimer, Kevin, Papi, Alberto, Pavord, Ian, Roche, Nicolas, Salvi, Sundeep, Sin, Don D, Singh, Dave, Stockley, Robert, López Varela, M Victorina, Wedzicha, Jadwiga A, Vogelmeier, Claus F

Volltext

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary von Agustí, Alvar, Celli, Bartolome R, Criner, Gerard J, Halpin, David, Anzueto, Antonio, Barnes, Peter, Bourbeau, Jean, Han, MeiLan K, Martinez, Fernando J, Montes de Oca, Maria, Mortimer, Kevin, Papi, Alberto, Pavord, Ian, Roche, Nicolas, Salvi, Sundeep, Sin, Don D, Singh, Dave, Stockley, Robert, López Varela, M Victorina, Wedzicha, Jadwiga A, Vogelmeier, Claus F

Volltext

Goals of COPD treatment: Focus on symptoms and exacerbations von Vogelmeier, Claus F., Román-Rodríguez, Miguel, Singh, Dave, Han, MeiLan K., Rodríguez-Roisin, Roberto, Ferguson, Gary T.

Volltext

Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial von Roche, Nicolas, Chapman, Kenneth R, Vogelmeier, Claus F, Herth, Felix J F, Thach, Chau, Fogel, Robert, Olsson, Petter, Patalano, Francesco, Banerji, Donald, Wedzicha, Jadwiga A

Volltext

Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study von Gloeckl, Rainer, Leitl, Daniela, Jarosch, Inga, Schneeberger, Tessa, Nell, Christoph, Stenzel, Nikola, Vogelmeier, Claus F, Kenn, Klaus, Koczulla, Andreas R

Volltext

Teaching medicine web-based with the help of interactive audience response systems von Kremer, Phillip, Richter, Leonard, Melms, Leander, Vogelmeier, Claus F, Schaefer, Juergen R

Volltext

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised tr... von Maltais, François, Bjermer, Leif, Kerwin, Edward M, Jones, Paul W, Watkins, Michael L, Tombs, Lee, Naya, Ian P, Boucot, Isabelle H, Lipson, David A, Compton, Chris, Vahdati-Bolouri, Mitra, Vogelmeier, Claus F

Volltext

GOLD 2024: a brief overview of key changes von Agusti, Alvar, Vogelmeier, Claus F

Volltext

IgE is associated with exacerbations and lung function decline in COPD von Lommatzsch, Marek, Speer, Timotheus, Herr, Christian, Jörres, Rudolf A, Watz, Henrik, Müller, Achim, Welte, Tobias, Vogelmeier, Claus F, Bals, Robert

Volltext

Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-... von Vogelmeier, Claus F, Prof, Bateman, Eric D, Prof, Pallante, John, BS, Alagappan, Vijay KT, MD, D'Andrea, Peter, MD, Chen, Hungta, PhD, Banerji, Donald, MD

Volltext

Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis von Greulich, Timm, Vogelmeier, Claus F.

Volltext

In 'real world' patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations von Worth, Heinrich, Buhl, Roland, Criée, Carl-Peter, Kardos, Peter, Gückel, Eva, Vogelmeier, Claus F

Volltext

Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world' study von Vogelmeier, Claus F, Worth, Heinrich, Buhl, Roland, Criée, Carl-Peter, Gückel, Eva, Kardos, Peter

Volltext

High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients - a retrospective analysis von Greulich, Timm, Tüffers, Julia, Mager, Sina, Eder, Anna, Maxheim, Michael, Alter, Peter, Schmeck, Bernd, Vogelmeier, Claus F

Volltext

Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review von Huber, Manuel B, Wacker, Margarethe E, Vogelmeier, Claus F, Leidl, Reiner

Volltext

Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany von Worth, Heinrich, Criée, Carl-Peter, Vogelmeier, Claus F, Kardos, Peter, Becker, Eva-Maria, Kostev, Karel, Mokros, Ingo, Schneider, Andrea

Volltext

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary von Agustí, Alvar, Celli, Bartolome R., Criner, Gerard J., Halpin, David, Anzueto, Antonio, Barnes, Peter, Bourbeau, Jean, Han, MeiLan K., Martinez, Fernando J., Montes de Oca, Maria, Mortimer, Kevin, Papi, Alberto, Pavord, Ian, Roche, Nicolas, Salvi, Sundeep, Sin, Don D., Singh, Dave, Stockley, Robert, López Varela, M. Victorina, Wedzicha, Jadwiga A., Vogelmeier, Claus F.

Volltext